Skybow PLX7500-Lead the Trend of 3D Imaging

3D imaging is continuously improving, with devices simultaneously becoming more manageable and mobile. The new C-arm system Skybow PLX7500 is opening up a new dimension.

Perlove’ s mobile C-arm set new benchmarks and greatly contribute to excellent precision in the OR – from image quality to operability, from versatility to efficiency.

3D Imaging

1.Main clinic Applications:

Orthopedics, General Surgery, Orthopedics, Trauma Surgery, Urology, Spine Surgery, Pain Sur gery, Gastroenterology, Endocrinology, Biliary Surgery, Hepatobiliary Surgery, Gastroenterology, Infection, Interventional, Oncology, Obstetrics and Gynecology, etc.

Intraoperative 3D imaging and Ct-like imaging provides precise information from every angle during the surgical procedures-pinpoint anatomical structures, implants and screws more confidently. Intuitive intraoperative 3D evaluation avoids unnecessary postoperative CT scans and corrective surgery, saving time and costs.

2. Our product can achieve a part of CT image effects

(2) Exceptional Ease of Use

1.No external cable between C-arm and chassis makes it easy to be surface of C-arm features an ti-microbial paint, maintaining a high level of infection control.

2.No external cable between C-arm and chassis makes it easy to be covered with sterile drapes. The surface of C-arm features anti-microbial paint, maintaining a high level of infection control.

3.Adjustable movement of panel detector allows for intraoperative fine-tuning of the distance between the detector and the subject, to receive more x-ray signal for clearer imaging based a certain dose.

(3)Multiple Screen Display

3. Clinical Image:

Assisted by the use of the Skybow PLX7500, lies in balancing cost-efficiency with improved patient care, less invasive procedures and shorter hospital stays.
This groundbreaking Skybow PLX7500 Mobile C-arm for surgical x-ray imaging helps to improve surgical outcomes and patient satisfaction whilst optmizing costs.
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Rencent News